Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Application of tumor measurement-based metrics in the real worldMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2020
Statistical Considerations for Subgroup AnalysesXiaofei Wang, Steven Piantadosi, Jennifer Le-Rademacher, et al.
Journal of Biopharmaceutical Statistics|November 8, 2018
An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cyclesYu Du, Jun Yin, Daniel J Sargent, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Clinical trial designs for prospective validation of biomarkersSumithra J Mandrekar, Axel Grothey, Matthew P Goetz, et al.
Mayo Clinic Proceedings|November 3, 2023
Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case StudiesDavid Zahrieh, Ivana T Croghan, Jonathan W Inselman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2020
Principles of Good Clinical Trial DesignMing-Wen An, Quyen Duong, Jennifer Le-Rademacher, et al.
Computational and Mathematical Methods in Medicine|February 5, 2015
The direct assignment option as a modular design component: an example for the setting of two predefined subgroupsMing-Wen An, Xin Lu, Daniel J Sargent, et al.
Contemporary Clinical Trials Communications|August 25, 2021
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trialsFang-Shu Ou, Jun Tang, Ming-Wen An, et al.
Biometrics|March 3, 2011
Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trialsBrian P Hobbs, Bradley P Carlin, Sumithra J Mandrekar, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Application of tumor measurement-based metrics in the real worldMing-Wen An, Sumithra J Mandrekar, Daniel J Sargent
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2020
Statistical Considerations for Subgroup AnalysesXiaofei Wang, Steven Piantadosi, Jennifer Le-Rademacher, et al.
Journal of Biopharmaceutical Statistics|November 8, 2018
An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cyclesYu Du, Jun Yin, Daniel J Sargent, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Clinical trial designs for prospective validation of biomarkersSumithra J Mandrekar, Axel Grothey, Matthew P Goetz, et al.
Mayo Clinic Proceedings|November 3, 2023
Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case StudiesDavid Zahrieh, Ivana T Croghan, Jonathan W Inselman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2020
Principles of Good Clinical Trial DesignMing-Wen An, Quyen Duong, Jennifer Le-Rademacher, et al.
Computational and Mathematical Methods in Medicine|February 5, 2015
The direct assignment option as a modular design component: an example for the setting of two predefined subgroupsMing-Wen An, Xin Lu, Daniel J Sargent, et al.
Contemporary Clinical Trials Communications|August 25, 2021
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trialsFang-Shu Ou, Jun Tang, Ming-Wen An, et al.
Biometrics|March 3, 2011
Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trialsBrian P Hobbs, Bradley P Carlin, Sumithra J Mandrekar, et al.
Pageof 16